A new personalized skin cancer treatment is showing success in preventing the return of high-risk melanoma. Five-year study results were announced on Tuesday by pharmaceutical companies Moderna Inc ...

Researchers found that differences in the amount of key bacterial groups in the gut predicted cancer recurrence with up to 94 ...

A revolutionary pancreatic cancer drug in late-stage clinical trials is extending the life of former Sen. Ben Sasse, but it ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...